1. Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, et al. Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge. Cells 2021; 10(3): 629. doi: 10.3390/cells10030629.
2. Center SA. Hepatic lipidosis, glucocorticoid hepatopathy, vascular hepatopathy, storage disorders, amyloidosis, and iron toxicity. In: Ettinger SJ, Feldman EC (Eds). Textbook of veterinary internal medicine: diseases of the dog and cat. 4th ed. Philadelphia, USA: WB Saunders 1996; 782-788/
3. Kaneko JJ, Harvey JW, Bruss ML. Clinical biochemistry of domestic animals. 6th ed. San Diego, USA: Academic Press (Elsevier) 2008: 932.
4. Zemlyanskyi A. Biochemical parameters of blood serum of dogs with hepatic lipidosis. J Vet Med Biotechnol Biosafety 2017; 3(1): 26-31.
5. Fang X, Cao J, Tao Z, et al. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway. Redox Rep 2023; 28(1): 2187564. doi: 10.1080/13510002. 2023.2187564.
6. Wu D, Wang L, Fan Z, et al. Comprehensive assessment of detoxification mechanisms of hydrolysis fish peptides in largemouth bass (Micropterus salmoides) under copper exposure: tracing from bioaccumulation, oxidative stress, lipid deposition to metabolomics. Ecotoxicol Environ Saf 2023; 264: 115418. doi: 10.1016/j.ecoenv.2023.115418.
7. Ortiz K, Cetin Z, Sun Y, et al. Human hepatocellular response in cholestatic liver diseases. Organogenesis 2023; 19(1): 2247576. doi: 10.1080/15476278. 2023.2247576.
8. Nguyen P, Leray V, Diez M, et al. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) 2008; 92(3): 272-283.
9. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20(6): 1442-1449.
10. Hirose N, Uchida K, Kanemoto H, et al. A retrospective histopathological survey on canine and feline liver diseases at the University of Tokyo between 2006 and 2012. J Vet Med Sci 2014; 76(7): 1015-1020.
11. Ettinger SJ, Feldman EC, Côté E. Textbook of veterinary internal medicine: diseases of the dog and cat. 6th ed. St. Louis, USA: Elsevier Saunders 2005: 1200-1500.
12. Biourge V. Feline hepatic lipidosis: prevention and treatment. In: Proceedings: The North American Veterinary Conference. Orlando, USA 2005; 397-399.
13. Dimski DS, Taboada J. Feline idiopathic hepatic lipidosis. Vet Clin North Am Small Anim Pract 1995; 25(2): 357-373.
14. Webb CB. Hepatic lipidosis: clinical review drawn from collective effort. J Feline Med Surg 2018; 20(3): 217-227.
15. Hunt GB, Luff JA, Daniel L, et al. Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using Oil Red O staining. Vet Pathol 2013; 50(6): 1109-1115.
16. Armstrong PJ, Blanchard G. Hepatic lipidosis in cats. Vet Clin North Am Small Anim Pract 2009; 39(3): 599-616.
17. Valtolina C, Favier RP. Feline hepatic lipidosis. Vet Clin North Am Small Anim Pract 2017; 47(3): 683-702.
18. Arunorat J, Chusakulwong N, Sakunasing N, et al. Comparative quantitation of liver-type fatty acid-binding protein localizations in liver injury and non-pathological liver tissue in dogs. Vet World 2024; 17(2): 313-318.
19. Gai Z, Wang T, Visentin M, et al. Lipid accumulation and chronic kidney disease. Nutrients 2019; 11(4): 722. doi: 10.3390/nu11040722.
20. Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 2016; 90(1): 41-52.
21. Vali Y, Molazem M, Yadegari M, et al. Quantitative evaluation of hepatic lipidosis in dogs. In Proceedings: The 4th International Symposium of Veterinary Surgery. Mashhad, Iran 2014; 99-101.